Top

Published in:

01-10-2019 | Hepatocellular Carcinoma | Case report

ET1402L1-CART

Transient elevation in AST and bilirubin: case report

Published in: Reactions Weekly | Issue 1/2019

Excerpt

A patient [age and sex not stated] experienced transient elevation in AST and bilirubin following treatment with ET1402L1-CART for α-fetoprotein (AFP)+ recurrent hepatocellular carcinoma. …

Peng M, et al. Safety and efficacy of repeated intra-hepatic artery and intravenous infusion of ET140202, a novel anti-AFP/MHC complex T-cell, in advanced hepatocellular carcinoma. Journal of Clinical Oncology 37 (Suppl. 15): abstr. e14013, May 2019. Available from: URL: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e14013 [abstract] - China

Title: ET1402L1-CART
Transient elevation in AST and bilirubin: case report
Publication date: 01-10-2019
Publisher: Springer International Publishing
Keywords: Hepatocellular Carcinoma
Hepatocellular Carcinoma
Published in: Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-69900-x

Sorafenib

Itraconazole
Case report

Immune-globulin

Cerebral Sinus Venous Thrombosis
Case report

Propylthiouracil

ANCA-Associated Vasculitis
Case report

Paracetamol

Paracetamol
Case report

Nivolumab

Hypothyroidism
Case report

Levodopa/carbidopa

Tachyarrythmia
Case report

Keynote series | Spotlight on menopause

Springer Medicine

ET1402L1-CART

Transient elevation in AST and bilirubin: case report

Excerpt

Other articles of this Issue 1/2019

Sorafenib

Immune-globulin

Propylthiouracil

Paracetamol

Nivolumab

Levodopa/carbidopa

Keynote series | Spotlight on menopause

Springer Medicine

Excerpt

Please log in to get access to this content

Sorafenib

Immune-globulin

Propylthiouracil

Paracetamol

Nivolumab

Levodopa/carbidopa